Location: Home> Products> Star Products
Click to return to the list
Common name: Tigrelor tablets
English name: Ticagrelor Tablets
Approval number: National Drug Standard H20193166
Indications: For patients with acute coronary syndrome (unstable angina, non-ST-segment elevation myocardial infarction or ST-segment elevation myocardial infarction), including patients receiving medication and percutaneous coronary intervention (PCI), Reduce the incidence of thrombotic cardiovascular events.